<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7434367\results\search\disease\results.xml">
  <result pre="chemo-preventive agents CegolonL.abâˆ—JavanbakhtM.cMastrangeloG.d[a], Marca Trevigiana[b], Burlo Garofolo[c], [d], âˆ—Corresponding author." exact="Local" post="Health Unit N.2 â€œMarca Trevigianaâ€�, Public Health Department, Treviso,"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="interferon-alpha, lactoferrin and hydroxychloroquine were tested in one-arm open label" exact="uncontrolled" post="clinical trial. Oxidant activity (hypothiocyanite, N-chlorotaurine and povidone-iodine), enhancement"/>
  <result pre="pH (quaternary ammonium compounds and hydroxychloroquine) and destruction of the" exact="viral" post="capsid (quaternary ammonium compounds, alcohol-based nasal antiseptics) were the"/>
  <result pre="the mouth is involved as exit site through emission of" exact="respiratory" post="droplets. The well-known hand-to-nose-to-hand cycle of contamination requires appropriate"/>
  <result pre="well-known hand-to-nose-to-hand cycle of contamination requires appropriate additional strategies for" exact="infection" post="control. To narrow down the subsequent laboratory and clinical"/>
  <result pre="Hypothiocyanite Lactoperoxidase Lactoferrin 1 Background 1.1 Rationale The current coronavirus" exact="disease" post="2019 (COVID-19), caused by the novel beta coronavirus SARS-CoV-2,"/>
  <result pre="2020). Unlike SARS-CoV-1, SARS-CoV-2 seems to replicate efficiently in the" exact="upper" post="airways during the incubation period, which is estimated to"/>
  <result pre="from infected cells (World Health Organization, 2020a). As a result," exact="viral" post="transmission is more effective with SARS-CoV-2 than with SARS-CoV-1,"/>
  <result pre="conversely was contagious only during the active/critical phase of the" exact="disease" post="(World Health Organization, 2020a). Furthermore, human coronaviruses which may"/>
  <result pre="coronaviruses which may cause common cold are known to cause" exact="respiratory" post="re-infections regardless of pre-existing humoral immunity (Gorse et al.,"/>
  <result pre="disease, which can range from pre-symptomatic/asymptomatic condition to life threatening" exact="pneumonia" post="featured by severe acute respiratory syndrome (SARS) and hypercoagulable"/>
  <result pre="from pre-symptomatic/asymptomatic condition to life threatening pneumonia featured by severe" exact="acute" post="respiratory syndrome (SARS) and hypercoagulable state (World Health Organization,"/>
  <result pre="pre-symptomatic/asymptomatic condition to life threatening pneumonia featured by severe acute" exact="respiratory" post="syndrome (SARS) and hypercoagulable state (World Health Organization, 2020a,"/>
  <result pre="condition to life threatening pneumonia featured by severe acute respiratory" exact="syndrome" post="(SARS) and hypercoagulable state (World Health Organization, 2020a, Cegolon"/>
  <result pre="of contagion from SARS-CoV-2 has been tackled so far by" exact="infection" post="prevention and control (IPC) measures such as self-isolation, social"/>
  <result pre="Currently, the World Health Organization and the European Center for" exact="Disease" post="Prevention and Control guidelines recommend testing only symptomatic individuals"/>
  <result pre="Center for Disease Prevention and Control guidelines recommend testing only" exact="symptomatic" post="individuals and close contacts of a confirmed COVID-19 case"/>
  <result pre="close contacts of a confirmed COVID-19 case (European Centre for" exact="Disease" post="Prevention and Control, 2020;; World Health Organization, 2020b). Whilst"/>
  <result pre="reported from a care home in Washington State, hosting a" exact="total" post="of 76 residents, 27 of the 48 residents testing"/>
  <result pre="China's National Health Commission, reporting that the vast majority of" exact="infections" post="(four out of five) were totally asymptomatic. In particular,"/>
  <result pre="five) were totally asymptomatic. In particular, 130 out of the" exact="total" post="166 new infections identified in China on April 1,"/>
  <result pre="asymptomatic. In particular, 130 out of the total 166 new" exact="infections" post="identified in China on April 1, 2020 had no"/>
  <result pre="still debated, and some evidence even points out a potential" exact="Antibody" post="Dependent Enhancement (ADE) triggered by secondary infections featuring the"/>
  <result pre="points out a potential Antibody Dependent Enhancement (ADE) triggered by" exact="secondary" post="infections featuring the severe/critical forms of COVID-19, as with"/>
  <result pre="out a potential Antibody Dependent Enhancement (ADE) triggered by secondary" exact="infections" post="featuring the severe/critical forms of COVID-19, as with other"/>
  <result pre="infections featuring the severe/critical forms of COVID-19, as with other" exact="viral" post="diseases such as Dengue, SARS-CoV-1, MERS-CoV and the West"/>
  <result pre="the above IPC measures, especially during cold months, and in" exact="absence of" post="a specific registered treatment or vaccine against SARS-CoV-2, there"/>
  <result pre="this article.) Therefore, in addition to an effective treatment for" exact="symptomatic" post="patients, there is an urgent need to abate the"/>
  <result pre="sulfenyl thiocyanate (R-S-SCN) or sulfenyl iodide (R-S-I), determining inhibition of" exact="bacterial" post="glycolysis, respiration and glucose transport. Inhibition of the pentose"/>
  <result pre="effective against E. coli than the SCNâˆ’ system, in that" exact="lower" post="Iâˆ’ concentrations are necessary (Bafort et al, 2014).. The"/>
  <result pre="OSCNâˆ’ seems able to alter the surface proteins of different" exact="respiratory" post="viruses, probably by oxidizing free thiol radicals and creating"/>
  <result pre="OSCNâˆ’ may also arguably hamper the synthesis and assemblance of" exact="viral" post="proteins and nucleic acids, thus interfering with the release"/>
  <result pre="2020). Due to the need of maximizing gas exchange, alveolar" exact="epithelial" post="cells cannot contain strong protective structures. The latter cells"/>
  <result pre="protective structures. The latter cells are fragile and vulnerable to" exact="infectious" post="agents, as shown by the diffuse alveolar damage discovered"/>
  <result pre="fragile and vulnerable to infectious agents, as shown by the" exact="diffuse" post="alveolar damage discovered in two patients undergoing surgical resections"/>
  <result pre="alveolar damage discovered in two patients undergoing surgical resections for" exact="lung adenocarcinoma," post="later discovered to be affected also by COVID-19 pneumonia"/>
  <result pre="lung adenocarcinoma, later discovered to be affected also by COVID-19" exact="pneumonia" post="(Tian et al., 2020). Bronchi were not reported to"/>
  <result pre="humans may explain the survival and proliferation of bacteria and" exact="respiratory" post="viruses in the mucosae of conjunctiva and nose and"/>
  <result pre="krusei) and viruses as HIV, herpes-simplex virus (HSV-1), adenovirus, echovirus," exact="respiratory" post="syncytial virus (RSV) and influenza virus (Moskwa et al.,"/>
  <result pre="effectively inactivated A/swine/Illinois/02860/09 (swH1N2) influenza A virions, successfully preventing the" exact="infection" post="of both primary human and male Sprague-Dawley rat trachea-bronchial"/>
  <result pre="(swH1N2) influenza A virions, successfully preventing the infection of both" exact="primary" post="human and male Sprague-Dawley rat trachea-bronchial epithelial cells (Gingerich"/>
  <result pre="infection of both primary human and male Sprague-Dawley rat trachea-bronchial" exact="epithelial" post="cells (Gingerich et al., 2016). In a more recent"/>
  <result pre="spectrum of action, a low level of resistance due to" exact="viral" post="mutations and limited adverse reactions can be predicted with"/>
  <result pre="a low level of resistance due to viral mutations and" exact="limited" post="adverse reactions can be predicted with OSCNâˆ’ (Cegolon and"/>
  <result pre="could be subsequently undertaken with the aim of providing a" exact="short" post="term-prophylaxis for the transmissibility of SARS-CoV-2, by clearing any"/>
  <result pre="clinical trial (RCT02598999) on healthy volunteers and patients affected by" exact="cystic fibrosis" post="and bronchiectasis (Alaxia, 2020). The LPO/H2O2/SCNâˆ’ system is also"/>
  <result pre="on healthy volunteers and patients affected by cystic fibrosis and" exact="bronchiectasis" post="(Alaxia, 2020). The LPO/H2O2/SCNâˆ’ system is also a commercially"/>
  <result pre="present in the human milk and can be found in" exact="external" post="secretions such as saliva, tears, milk, nasal and bronchial"/>
  <result pre="a constituent of the human innate immune response and during" exact="viral" post="infections the expression of genes encoding LF was found"/>
  <result pre="constituent of the human innate immune response and during viral" exact="infections" post="the expression of genes encoding LF was found to"/>
  <result pre="RNA and DNA viruses, such as HIV, Zika virus, Chikungunya," exact="hepatitis C" post="virus, cytomegalovirus, rotavirus, among others (Martorell et al., 2016;"/>
  <result pre="2011). As shown in Fig. 3 , LF blocks the" exact="infection" post="of SARS-CoV-1 by competing with the virus for HSPGs"/>
  <result pre="et al., 2011). This mechanism of action could prevent the" exact="viral" post="concentration on the cell surface, as well as to"/>
  <result pre="of Lactoferrin (LF) in SARS-CoV infection. (A) LF blocks the" exact="infection" post="of SARS-CoV by binding to cell surface heparan sulfate"/>
  <result pre="binding to cell surface heparan sulfate proteoglycans (HSPGs). (B) In" exact="absence of" post="LF, the anchoring sites provided by HSPGs allow the"/>
  <result pre="of 24 commercial products containing LF and available by the" exact="American" post="corporation Amazon. A randomized, open-label, parallel-group clinical trial was"/>
  <result pre="al., 2018). The incidence and duration of common cold, influenza" exact="infection" post="and gastrointestinal symptoms was not statistically different between treatment"/>
  <result pre="has been proposed as a possible therapeutic intervention for the" exact="disease" post="(Zhang and Liu, 2020). An oral supplement combining a"/>
  <result pre="and 4â€&quot;6 times/day was administered for 10 days to 75" exact="symptomatic" post="COVID-19 patients tested positive for IgM/IgG rapid test and"/>
  <result pre="LLF on 256 household contacts was effective to prevent SARS-CoV-2" exact="infection" post="(Serrano et al., 2020). Last but not least, out"/>
  <result pre="clinical trial (RCT02598999) on healthy volunteers and patients affected by" exact="cystic fibrosis" post="(Alaxia, 2020; Cegolon, 2020). 3.3 N-chlorotaurine N-chlorotaurine (NCT) is"/>
  <result pre="activity against bacteria, fungi, parasites and viruses (Herpes simplex virus" exact="type 1;" post="Herpes simplex virus type 2; Adenovirus; Influenza virus A"/>
  <result pre="and viruses (Herpes simplex virus type 1; Herpes simplex virus" exact="type 2;" post="Adenovirus; Influenza virus A and HIV-1). NCT can be"/>
  <result pre="mucous membranes and paranasal sinuses. The ciliary beat frequency of" exact="epithelial" post="cells of the nasal mucosa, a very sensitive parameter"/>
  <result pre="plays a critical role in anti-viral immunity, interfering with the" exact="viral" post="replication and spread with different mechanisms, including inhibition of"/>
  <result pre="vitro investigation confirmed the efficacy of IFN-Î± against SARS-like coronavirus" exact="infections" post="(Zorzitto et al., 2006). Animal tests have confirmed that"/>
  <result pre="host cells, thus in turn reducing their ability to suppress" exact="viral" post="infections (Cegolon et al, 2020). Therefore, the use of"/>
  <result pre="cells, thus in turn reducing their ability to suppress viral" exact="infections" post="(Cegolon et al, 2020). Therefore, the use of exogenous"/>
  <result pre="no study subject was positive for COVID-19 and nobody developed" exact="respiratory" post="symptoms (Meng et al., 2020). The latter investigation was"/>
  <result pre="group used was composed by medical staff affected by COVID-19" exact="pneumonia" post="and recruited from the epidemic area during the same"/>
  <result pre="peer review. Although IFN is seemingly effective to disinfect the" exact="upper" post="airways from COVID-19, its use may be more appropriate"/>
  <result pre="as disinfectant since 1955. The air-liquid interface of human nasal" exact="epithelial" post="cells cultures collected from patients affected by chronic rhinosinusitis"/>
  <result pre="human nasal epithelial cells cultures collected from patients affected by" exact="chronic" post="rhinosinusitis were recently exposed in vitro to a 0.5%"/>
  <result pre="nasal epithelial cells cultures collected from patients affected by chronic" exact="rhinosinusitis" post="were recently exposed in vitro to a 0.5% solution"/>
  <result pre="observed on paracellular permeability or cilia beat frequency. The trans" exact="epithelial" post="electrical resistance of cultured cells was significantly reduced only"/>
  <result pre="may not be optimal for pregnant women and children though." exact="Hypothyroidism" post="has in fact been reported with povidone-iodine antiseptics in"/>
  <result pre="an asymtpomatic mother has been reported (Jafari et al., 2020)." exact="Transient" post="hyper-thyrotropinemia can occur in neonates whose mothers had been"/>
  <result pre="effects in terms of QTc prolongation and haemolysis associated with" exact="deficiency" post="of glucose-6-phosphate dehydrogenase (Tilangi et al., 2020). On this"/>
  <result pre="least 60% ethanol are recommended by the USA Centre for" exact="Disease" post="Control and Prevention (CDC) for hand hygiene of health"/>
  <result pre="studies tested the effectiveness of alcohol-based antiseptics in reducing nasal" exact="bacterial" post="carriage in health care professionals at an urban hospital"/>
  <result pre="a controlled inhalation of ethanol vapor obtained from readily available" exact="alcoholic" post="beverages (whisky or Japanese sake), to disinfect the human"/>
  <result pre="associated spike glycoproteins interacting with the ACE2 receptor in the" exact="infection" post="of host cells. Another mechanism of action entails raising"/>
  <result pre="possible antiviral activity against coronaviruses. â€¢Ammonium chloride. Various uses, including" exact="metabolic acidosis." post="Viral activity against murine coronavirus and hepatitis C. â€¢Cetylpyridinium"/>
  <result pre="activity against coronaviruses. â€¢Ammonium chloride. Various uses, including metabolic acidosis." exact="Viral" post="activity against murine coronavirus and hepatitis C. â€¢Cetylpyridinium chloride."/>
  <result pre="uses, including metabolic acidosis. Viral activity against murine coronavirus and" exact="hepatitis C." post="â€¢Cetylpyridinium chloride. Used as antiseptic, mouthwash, personal care products,"/>
  <result pre="was tested in a clinical trial as a treatment against" exact="respiratory" post="infections (Mukherjee et al., 2017). Cetylpyridinium chloride has anti-viral"/>
  <result pre="tested in a clinical trial as a treatment against respiratory" exact="infections" post="(Mukherjee et al., 2017). Cetylpyridinium chloride has anti-viral activity"/>
  <result pre="et al., 2017). Cetylpyridinium chloride has anti-viral activity against Influenza," exact="hepatitis" post="B, poliovirus 1. â€¢Miramistin. Antiseptic with antiviral activity against"/>
  <result pre="poliovirus 1. â€¢Miramistin. Antiseptic with antiviral activity against HIV, influenza," exact="herpes" post="simplex virus and SARS-CoV-1. QACs such as cetylpyridinium chloride"/>
  <result pre="well-known hand-to-nose-to-hand cycle of contamination requires appropriate additional methods for" exact="infection" post="control. The present scoping review identified knowledge gaps more"/>
  <result pre="on healthcare servicesAvailable from:https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-guidance-health-systems-contingency-planning.pdf2020 AlaxiaALX â€&quot; 009Available from:https://www.alaxia-pharma.eu/alx-009/ AronsM.M.HatfieldK.M.ReddyS.C.Pre-symptomatic SARS-CoV-2" exact="infections" post="and transmission in a skilled nursing facilityN. Engl. J."/>
  <result pre="of lactoferrin-A natural immunity moleculeMolecules1620116992701821847071 BidraA.S.PelletierJ.S.WestoverJ.B.FrankS.BrownS.M.TessemaB.Rapid inâ€�vitro inactivation of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARSâ€�CoVâ€�2) using povidoneâ€�iodine oral antiseptic"/>
  <result pre="lactoferrin-A natural immunity moleculeMolecules1620116992701821847071 BidraA.S.PelletierJ.S.WestoverJ.B.FrankS.BrownS.M.TessemaB.Rapid inâ€�vitro inactivation of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARSâ€�CoVâ€�2) using povidoneâ€�iodine oral antiseptic rinseJ."/>
  <result pre="natural immunity moleculeMolecules1620116992701821847071 BidraA.S.PelletierJ.S.WestoverJ.B.FrankS.BrownS.M.TessemaB.Rapid inâ€�vitro inactivation of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARSâ€�CoVâ€�2) using povidoneâ€�iodine oral antiseptic rinseJ. Prosthodont.296202052955332511851"/>
  <result pre="the risk for COVID-19 infection?Int. J. Immunopathol. Pharmacol.342020 Janâ€&quot;Dec2058738420941757 CasteelsK.PÃ¼ntS.BrÃ¤mswigJ.Transient" exact="neonatal" post="hypothyroidism during breastfeeding after post-natal maternal topical iodine treatmentEur."/>
  <result pre="risk for COVID-19 infection?Int. J. Immunopathol. Pharmacol.342020 Janâ€&quot;Dec2058738420941757 CasteelsK.PÃ¼ntS.BrÃ¤mswigJ.Transient neonatal" exact="hypothyroidism" post="during breastfeeding after post-natal maternal topical iodine treatmentEur. J."/>
  <result pre="breastfeeding after post-natal maternal topical iodine treatmentEur. J. Pediatr.1599200071611014479 CDCCoronavirus" exact="Disease" post="2019 (COVID-19):How to Protect Yourself &amp;amp; Others. Centers for"/>
  <result pre="Disease 2019 (COVID-19):How to Protect Yourself &amp;amp; Others. Centers for" exact="Disease" post="Control and PreventionCoronavirus Disease 2019 (COVID-19)2020https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html CegolonL.Investigating hypothiocyanite against"/>
  <result pre="Protect Yourself &amp;amp; Others. Centers for Disease Control and PreventionCoronavirus" exact="Disease" post="2019 (COVID-19)2020https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html CegolonL.Investigating hypothiocyanite against SARS-CoV-2Int. J. Hyg Environ."/>
  <result pre="ConnerG.E.Wijkstrom-FreiC.RandellS.H.FernandezV.E.SalatheM.The lactoperoxidase system links anion transport to host defense in" exact="cystic" post="fibrosisFEBS Lett.581200727127817204267 CouchR.B.Medical Microbiology1995University of Texas Medical BranchGalveston122 DayM.Covid-19:"/>
  <result pre="and therapeutic effects of recombinant IFN-alpha2b nasal spray for SARS-CoV" exact="infection" post="in Macaca mulataZhonghua Shi Yan He Lin Chuang Bing"/>
  <result pre="Situation in ItalyAvailable from:https://lab.gedidigital.it/gedi-visual/2020/coronavirus-i-contagi-in-italia/ GingerichA.PangL.HansonJ.DlugolenskiD.StreichR.LafontaineE.R.NagyT.TrippR.A.RadaB.Hypothiocyanite produced by human and rat" exact="respiratory" post="epithelial cells inactivates extracellular H1N2 influenza A virusInflamm. Res.652016718026608498"/>
  <result pre="in ItalyAvailable from:https://lab.gedidigital.it/gedi-visual/2020/coronavirus-i-contagi-in-italia/ GingerichA.PangL.HansonJ.DlugolenskiD.StreichR.LafontaineE.R.NagyT.TrippR.A.RadaB.Hypothiocyanite produced by human and rat respiratory" exact="epithelial" post="cells inactivates extracellular H1N2 influenza A virusInflamm. Res.652016718026608498 GiudicessiJ.R.NoseworthyP.A.FriedmanP.A.AckermanM.J.Urgent"/>
  <result pre="the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus" exact="disease" post="19 (COVID-19)Mayo Clin. Proc.202010.1016/j.mayocp.2020.03.024published online April 7 GorseG.J.DonovanM.M.PatelG.B.Antibodies to"/>
  <result pre="fever, dyspnea and poor feeding, diagnosed with COVID-19Travel Medicine and" exact="Infectious" post="Disease36101789202010.1016/j.tmaid.2020.101789In this issue JakimovskiD.KolbC.RamanathanM.ZivadinovR.Weinstock-GuttmanB.Interferon Î² for multiple sclerosisCold Spring"/>
  <result pre="help defend against viruses and bacteriaFront. Immunol.112020122132574271 KratzelATodtDVâ€™kovskiPSteinerSGultromMInactivation of severe" exact="acute" post="respiratory syndrome coronavirus 2 by WHO-Recommended Hand Rub Formulations"/>
  <result pre="defend against viruses and bacteriaFront. Immunol.112020122132574271 KratzelATodtDVâ€™kovskiPSteinerSGultromMInactivation of severe acute" exact="respiratory" post="syndrome coronavirus 2 by WHO-Recommended Hand Rub Formulations and"/>
  <result pre="against viruses and bacteriaFront. Immunol.112020122132574271 KratzelATodtDVâ€™kovskiPSteinerSGultromMInactivation of severe acute respiratory" exact="syndrome" post="coronavirus 2 by WHO-Recommended Hand Rub Formulations and AlcoholsEmerg"/>
  <result pre="of SARS-CoV-2 by commercially available alcohol-based hand sanitizersAmerian Journal of" exact="Infection" post="Control202010.1016/j.ajic.2020.08.020In press LiuJ.CaoR.XuM.WangX.ZhangH.HuH.Hydroxychloroquine, a less toxic derivative of chloroquine,"/>
  <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discov620201632194981 MarcozziG.LiberatiV.MadiaF.PizzingaA.de FeoG.Effect of hormone replacement therapy"/>
  <result pre="in vitroCell Discov620201632194981 MarcozziG.LiberatiV.MadiaF.PizzingaA.de FeoG.Effect of hormone replacement therapy on" exact="lacrimal" post="fluid peroxidase activity in womanMaturitas453200322522912818468 MartorellP.LlopisS.GonzalezN.RamÃ³nD.SerranoG.TorrensA.SerranoJ.M.NavarroM.GenovÃ©sS.A nutritional supplement containing"/>
  <result pre="of recombinantX human interferon alpha nasal drops to prevent coronavirus" exact="disease" post="2019 in medical staff in an epidemic areaMedRxiv2020Available from:https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v2(last"/>
  <result pre="epidemic areaMedRxiv2020Available from:https://www.medrxiv.org/content/10.1101/2020.04.11.20061473v2(last accessed on 24th August 2020) MikolaH.WarisM.TenovuoJ.Inhibition of" exact="herpes" post="simplex virus type 1, respiratory syncytial virus and echovirus"/>
  <result pre="accessed on 24th August 2020) MikolaH.WarisM.TenovuoJ.Inhibition of herpes simplex virus" exact="type 1," post="respiratory syncytial virus and echovirus type 11 by peroxidase-generated"/>
  <result pre="24th August 2020) MikolaH.WarisM.TenovuoJ.Inhibition of herpes simplex virus type 1," exact="respiratory" post="syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyaniteAntivir."/>
  <result pre="herpes simplex virus type 1, respiratory syncytial virus and echovirus" exact="type 11" post="by peroxidase-generated hypothiocyaniteAntivir. Res.2619951611717605114 MoskwaP.LorentzenD.ExcoffonK.J.ZabnerJ.McCrayP.B.Jr.NauseefW.M.DupuyC.BanfiB.A novel host defense system"/>
  <result pre="MoskwaP.LorentzenD.ExcoffonK.J.ZabnerJ.McCrayP.B.Jr.NauseefW.M.DupuyC.BanfiB.A novel host defense system of airways is defective in" exact="cystic" post="fibrosisAm. J. Respir. Crit. Care Med.175200717418317082494 MukherjeeP.K.EsperF.BuchheitK.ArtersK.AdkinsI.GhannoumM.A.Randomized, double-blind, placebo"/>
  <result pre="and effectiveness of a nove dual-action oral topical formulation against" exact="upper" post="respiratory infectionsBMC Infect. Dis.17120177428088167 NaglM.ArnitzR.LacknerM.N-chlorotaurine, a promising future candidate"/>
  <result pre="effectiveness of a nove dual-action oral topical formulation against upper" exact="respiratory" post="infectionsBMC Infect. Dis.17120177428088167 NaglM.ArnitzR.LacknerM.N-chlorotaurine, a promising future candidate for"/>
  <result pre="lactoferrin, a further arrow in the quiver of preventionJournal of" exact="Pediatric" post="and Neonatal Individualized Medicine912020e090142 PourtoisM.BinetC.Van TieghemN.CourtoisP.VandenabbeeleA.ThiryL.Inhibition of HIV infectivity"/>
  <result pre="further arrow in the quiver of preventionJournal of Pediatric and" exact="Neonatal" post="Individualized Medicine912020e090142 PourtoisM.BinetC.Van TieghemN.CourtoisP.VandenabbeeleA.ThiryL.Inhibition of HIV infectivity by lactoperoxidase-produced"/>
  <result pre="safety evaluation of a povidone-iodine solution applied to human nasal" exact="epithelial" post="cellsInt Forum Allergy Rhinol20202020 Apr 6([Online ahead of print])"/>
  <result pre="print]) ReghunathanR.JayapalM.HsuL.ChngH.TaiD.Expression profile of immune response genes in patients with" exact="Severe" post="Acute Respiratory SyndromeBMC Immunol.62005215655079 ReiterB.MarshallV.M.E.BjorckL.RosenC.-G.Nonspecific bactericidal activity of the"/>
  <result pre="ReghunathanR.JayapalM.HsuL.ChngH.TaiD.Expression profile of immune response genes in patients with Severe" exact="Acute" post="Respiratory SyndromeBMC Immunol.62005215655079 ReiterB.MarshallV.M.E.BjorckL.RosenC.-G.Nonspecific bactericidal activity of the lactoperoxidase-thiocyanate"/>
  <result pre="profile of immune response genes in patients with Severe Acute" exact="Respiratory" post="SyndromeBMC Immunol.62005215655079 ReiterB.MarshallV.M.E.BjorckL.RosenC.-G.Nonspecific bactericidal activity of the lactoperoxidase-thiocyanate hydrogen"/>
  <result pre="in New York stateJ. Am. Med. Assoc.32324202024932502 RotheC.SchunkM.SothmannP.Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in GermanyN. Engl. J. Med.38210202097097132003551"/>
  <result pre="Health Sci.12520184450 ShintakeT.Possibility of Disinfection of SARS-CoV-2 (COVID-19) in Human" exact="Respiratory" post="Tract by Controlled Ethanol Vapor Inhalation. ArXiv - Cornell"/>
  <result pre="Sci.12520184450 ShintakeT.Possibility of Disinfection of SARS-CoV-2 (COVID-19) in Human Respiratory" exact="Tract" post="by Controlled Ethanol Vapor Inhalation. ArXiv - Cornell UniversityAvailable"/>
  <result pre="actionInfect. Immun.201978456463352945 TianS.HuW.NiuL.LiuH.XuH.XiaoS.Y.Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19)" exact="pneumonia" post="in two patients with lung cancerThorac Oncol1552020700704 TilangiP.DesaiD.KhanA.SonejaM.Hydroxychloroquine prophylaxis"/>
  <result pre="lactoferrin prevents body weight loss and increases cytokine responses during" exact="herpes" post="simplex virus type 1 infection of miceBiosci. Biotechnol. Biochem.68200453754415056884"/>
  <result pre="weight loss and increases cytokine responses during herpes simplex virus" exact="type 1" post="infection of miceBiosci. Biotechnol. Biochem.68200453754415056884 WangA.DuncanS.E.LesserG.L.Effect of lactoferrin on"/>
  <result pre="and increases cytokine responses during herpes simplex virus type 1" exact="infection" post="of miceBiosci. Biotechnol. Biochem.68200453754415056884 WangA.DuncanS.E.LesserG.L.Effect of lactoferrin on taste"/>
  <result pre="the Transmission of COVID-192020SSRN World Health OrganizationLaboratory testing for coronavirus" exact="disease" post="(COVID-19) in suspected human cases- interim guidanceAvailable from:https://apps.who.int/iris/handle/10665/331501 World"/>
  <result pre="in suspected human cases- interim guidanceAvailable from:https://apps.who.int/iris/handle/10665/331501 World Health OrganizationCoronavirus" exact="Disease" post="2019 (CVOID-19)Situation reports - 30. Available from:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200219-sitrep-30-covid-19.pdf?sfvrsn=3346b04f_2 WorldometersCoronavirusAvailable from:https://www.worldometers.info/coronavirus/"/>
  <result pre="the prefusion conformationScience36720201260126332075877 YaoM.ZhangL.MaJ.ZhouL.On airborne transmission and control of SARS-Cov-2Sci." exact="Total" post="Environ.731202013917832388162 YuP.ZhuJ.ZhangZ.HanY.HuangL.A familial cluster of infection associated with the"/>
  <result pre="YaoM.ZhangL.MaJ.ZhouL.On airborne transmission and control of SARS-Cov-2Sci. Total Environ.731202013917832388162 YuP.ZhuJ.ZhangZ.HanY.HuangL.A" exact="familial" post="cluster of infection associated with the 2019 novel coronavirus"/>
  <result pre="and control of SARS-Cov-2Sci. Total Environ.731202013917832388162 YuP.ZhuJ.ZhangZ.HanY.HuangL.A familial cluster of" exact="infection" post="associated with the 2019 novel coronavirus indicating potential person-to-person"/>
  <result pre="of the antiviral effects of interferon-alpha against a SARS-like coronavirus" exact="infection" post="in vitroCell Res.162200622022916474437"/>
 </snippets>
</snippetsTree>
